HILDA ANIGBOGU: Open Payments
NPI 1083258875 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 25 payments from 6 companies in 2025. Trend: 2023 $210 · 2024 $390 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $114 |
| Indivior Inc. | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: VRAYLAR, CAPLYTA, SUBLOCADE, COBENFY, REXULTI, INVEGA SUSTENNA.
Industry payments across MA — which companies pay providers there.
